Biblio Discovery — Demo Discovery Service

24 results for "Almut Scherer"

Showing 1–20 · 0.94 seconds · RSS

  1. Journal Article Full text

    High epitope expression levels increase competition between T cells.

    Almut Scherer; Marcel Salathé; Sebastian Bonhoeffer

    PLoS Computational Biology, Vol. 2 No. 8 · 2006 · English · DOAJ Scopus

    Both theoretical predictions and experimental findings suggest that T cell populations can compete with each other. There is some debate on whether T cells compete for aspecific stimuli, such as access to the surface on antigen-presenting cells (APCs) or for specific stimuli, such as their cognate…

    Also available at: PLOS

  2. Journal Article Full text

    Personalized prediction of disease activity in patients with rheumatoid arthritis using an adaptive deep neural network

    Maria Kalweit; Ulrich A. Walker; Axel Finckh et al.

    PLOS ONE, Vol. 16 No. 6 · 2021 · English · PLOS Scopus

    Background: Deep neural networks learn from former experiences on a large scale and can be used to predict future disease activity as potential clinical decision support. AdaptiveNet is a novel adaptive recurrent neural network optimized to deal with heterogeneous and missing clinical data…

    Also available at: DOAJ

  3. Journal Article Full text

    Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis

    Monika Hebeisen; Almut Scherer; Raphael Micheroli et al.

    PLOS ONE, Vol. 14 No. 5 · 2019 · English · PLOS Scopus

    Objectives: To compare drug survival in patients with axial spondyloarthritis treated with different TNF inhibitors in standard dosage. Methods: Patients fulfilling the Assessment in SpondyloArthritis international Society classification criteria for axial spondyloarthritis in the Swiss Clinical…

    Also available at: DOAJ

  4. Journal Article

    Sacroiliac joint radiographic progression in axial spondyloarthritis is retarded by the therapeutic use of TNF inhibitors: 12-year data from the SCQM registry

    Oliver Distler; Raphael Micheroli; Almut Scherer et al.

    RMD Open, Vol. 8 No. 2 · 2022 · English · DOAJ Scopus

    Objectives To analyse the effect of tumour necrosis factor inhibitors (TNFi) on sacroiliac joint (SIJ) radiographic progression in axial spondyloarthritis (axSpA).Methods Patients with axSpA in the Swiss Clinical Quality Management cohort with up to 12 years of follow-up and radiographic…

  5. Journal Article

    Differences between men and women with nonradiographic axial spondyloarthritis: clinical characteristics and treatment effectiveness in a real-life prospective cohort

    Regula Neuenschwander; Monika Hebeisen; Raphael Micheroli et al.

    Arthritis Research & Therapy, Vol. 22 No. 1 · 2020 · English · DOAJ Scopus

    Abstract Background Sex differences with regard to clinical manifestations and response to tumor necrosis factor inhibitors (TNFi) have been delineated for the radiographic form of axial spondyloarthritis (axSpA). More limited evidence for a differential effectiveness of treatment in genders exists…

  6. Journal Article

    Impact of assessing patient-reported outcomes with mobile apps on patient–provider interaction

    Axel Finckh; Delphine S Courvoisier; Thomas Lehmann et al.

    RMD Open, Vol. 7 No. 1 · 2021 · English · DOAJ Scopus

    Objective To explore the effect of apps measuring patient-reported outcomes (PROs) on patient–provider interaction in the rheumatic diseases in an observational setting.Methods Patients in the Swiss Clinical Quality Management in Rheumatic Diseases Registry were offered mobile apps (iDialog and…

  7. Journal Article

    Characterisation of patients with axial psoriatic arthritis and patients with axial spondyloarthritis and concomitant psoriasis in the SCQM registry

    Adrian Ciurea; Michael J Nissen; Raphael Micheroli et al.

    RMD Open, Vol. 9 No. 2 · 2023 · English · DOAJ Scopus

    Background Within the spectrum of spondyloarthritides, axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) present with overlapping features. Axial involvement in PsA (axial PsA) is treated according to recommendations for axSpA, as specific studies in axial PsA are scarce. We compared…

  8. Journal Article

    Site-specific resolution of enthesitis in patients with axial spondyloarthritis treated with tumor necrosis factor inhibitors

    Michael J. Nissen; Burkhard Möller; Adrian Ciurea et al.

    Arthritis Research & Therapy, Vol. 23 No. 1 · 2021 · English · DOAJ Scopus

    Abstract Background Enthesitis is a hallmark of spondyloarthritis (SpA) with a substantial impact on quality of life. Reports of treatment effectiveness across individual enthesitis sites in real-world patients with axial SpA (axSpA) are limited. We investigated the evolution of enthesitis…

  9. Journal Article Full text

    Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohort

    Monika Hebeisen; Raphael Micheroli; Almut Scherer et al.

    PLOS ONE, Vol. 15 No. 3 · 2020 · English · PLOS Scopus

    Objective: To investigate whether spinal radiographic progression relates to structural damage at the sacroiliac level in axial spondyloarthritis (axSpA). Methods: Patients classified as nonradiographic (nr-) and radiographic (r-) axSpA in the Swiss Clinical Quality Management cohort with…

    Also available at: DOAJ

  10. Journal Article

    Impact of sex on spinal radiographic progression in axial spondyloarthritis: a longitudinal Swiss cohort analysis over a period of 10 years

    Xenofon Baraliakos; Oliver Distler; Adrian Ciurea et al.

    RMD Open, Vol. 9 No. 3 · 2023 · English · DOAJ Scopus

    Objective To investigate sex differences in spinal radiographic progression in axial spondyloarthritis (axSpA).Methods AxSpA patients in the Swiss Clinical Quality Management cohort with available spinal radiographs every 2 years were included. Paired radiographs were scored by two readers…

  11. Journal Article

    Site-specific assessment of spinal radiographic progression improves detection of TNF blocker-associated disease modification in axial spondyloarthritis: longitudinal observational data from the Swiss Clinical Quality Management Registry

    Vjara Popova; Seraphina Kissling; Raphael Micheroli et al.

    Arthritis Research & Therapy, Vol. 25 No. 1 · 2023 · English · DOAJ Scopus

    Abstract Objectives To analyse whether time-varying treatment with tumour necrosis factor inhibitors (TNFi) in radiographic axial spondyloarthritis (r-axSpA) has a differential impact on structural damage progression on different spinal segments (cervical versus lumbar spine). Methods Patients with…

  12. Journal Article

    Early axial spondyloarthritis according to the ASAS consensus definition: characterisation of patients and effectiveness of a first TNF inhibitor in a large observational registry

    Oliver Distler; Diego Kyburz; Adrian Ciurea et al.

    RMD Open, Vol. 9 No. 4 · 2023 · English · DOAJ Scopus

    Objective To characterise the population fulfilling the Assessment of SpondyloArthritis international Society (ASAS) consensus definition of early axial spondyloarthritis (axSpA) and to determine the effectiveness of a first tumour necrosis factor inhibitor (TNFi) in early versus established axSpA…

  13. Journal Article

    Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis

    Raphael Micheroli; Monika Hebeisen; Lukas M. Wildi et al.

    Arthritis Research & Therapy, Vol. 19 No. 1 · 2017 · English · DOAJ Scopus

    Abstract Background Few studies have investigated the impact of obesity on the response to tumor necrosis factor inhibitors (TNFi) in patients with axial spondyloarthritis (axSpA). The aim of our study was to investigate the impact of different body mass index (BMI) categories on TNFi response in a…

  14. Journal Article

    Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care

    Myriam Riek; Almut Scherer; Burkhard Möller et al.

    Scientific Reports, Vol. 13 No. 1 · 2023 · English · DOAJ Scopus

    Abstract Recently, serious infections related to the use of tofacitinib (TOF) for treatment of rheumatoid arthritis (RA) have raised considerable interest. This study aimed to compare the risk for serious infections in patients with RA upon receiving TOF versus biologic disease-modifying…

  15. Journal Article

    Longer Drug Retention of Interleukin-12/23 or Interleukin-17 Inhibitors Compared With TNF Inhibitors in Female Patients With TNF Inhibitor-Experienced Psoriatic Arthritis

    Godehard A. Scholz, MD, PhD; Eleftherios Papagiannoulis, MSc; Christoph Blapp, MSc et al.

    Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol. 9 No. 3 · 2025 · English · DOAJ Scopus

    Objective: To compare the effectiveness of Interleukin (IL)-12/23 or IL-17A inhibitors (summarized to inhibitors of the Th17 cell generation or function, Th17i) with tumor necrosis factor inhibitors (TNFi) in patients with TNFi-experienced psoriatic arthritis (PsA). Patients and Methods: We…